Cosomil, Inc. is an innovative start-up dedicated to advancing early cancer detection through the development of blood-based tests. Our groundbreaking technology, known as Single Enzyme Activity-based Protein Profiling, enables ultra-sensitive detection of enzyme activity at the single molecule level using state-of-the-art fluorescent probes and microdevices.
コウソミル株式会社は、蛍光プローブとマイクロデバイスを用いて血液中の酵素の活性を1分子レベルの超高感度で検出する独自の「1分子計測リキッドバイオプシー」技術を用いて、癌等の早期疾患診断法の研究開発を行なうスタートアップ企業です。
Company Details
- Employees
- 5
- Founded
- -
- Address
- 本郷7-3-1, 東京都文京区,東京都 113-0033,japan
- Industry
- Biotechnology
- Website
- https://cosomil.com
- HQ
- 東京都文京区, 東京都
Cosomil, Inc. Questions
Cosomil, Inc.'s website is https://cosomil.com
Cosomil, Inc.'s LinkedIn profile is https://jp.linkedin.com/company/cosomil
Cosomil, Inc. has
5 employees.
View email and phone details for 5
employees at Cosomil, Inc..
Cosomil, Inc.'s industry is
Biotechnology
Cosomil, Inc.'s top competitors are
Luca Science Inc.,
Plusman Llc,
Genoplan,
Digzyme, Inc,
Sanbio,
Bgf Plantrix,
Rege Nephro Co., Ltd.,
Dna Link,
Fimecs, Inc.,
Genoplan Asia Pacific.
Cosomil, Inc.'s categories are Biotechnology
Cosomil, Inc.'s founding year is 2022
